Canopy Growth Corporation (CGC)
NASDAQ: CGC · Real-Time Price · USD
1.460
+0.150 (11.45%)
At close: May 12, 2025, 4:00 PM
1.431
-0.029 (-2.02%)
After-hours: May 12, 2025, 7:55 PM EDT
Canopy Growth Revenue
Canopy Growth had revenue of 74.76M CAD in the quarter ending December 31, 2024, a decrease of -4.77%. This brings the company's revenue in the last twelve months to 276.75M, down -5.41% year-over-year. In the fiscal year ending March 31, 2024, Canopy Growth had annual revenue of 297.15M, down -10.83%.
Revenue (ttm)
276.75M CAD
Revenue Growth
-5.41%
P/S Ratio
1.20
Revenue / Employee
268,952 CAD
Employees
1,029
Market Cap
231.57M USD
Revenue Chart
* This company reports financials in CAD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 297.15M | -36.11M | -10.83% |
Mar 31, 2023 | 333.25M | -142.45M | -29.94% |
Mar 31, 2022 | 475.70M | -70.95M | -12.98% |
Mar 31, 2021 | 546.65M | 147.88M | 37.08% |
Mar 31, 2020 | 398.77M | 172.43M | 76.18% |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
CGC News
- 7 hours ago - SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Canopy Growth - Accesswire
- 22 hours ago - The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of June 3, 2025 in Canopy Growth Corporation Lawsuit - CGC - PRNewsWire
- 6 days ago - Canopy Growth Drives Innovation in High-Demand Segments With Latest Product Launches - Business Wire
- 8 days ago - High Potential: Canadian Cannabis Stocks Making Waves in May 2025 - MarijuanaStocks
- 12 days ago - SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Canopy Growth - Accesswire
- 20 days ago - April 2025's Canadian Cannabis Stock Picks: Growth and Opportunity - MarijuanaStocks
- 4 weeks ago - The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of June 3, 2025 in Canopy Growth Corporation Lawsuit – CGC - GlobeNewsWire
- 4 weeks ago - Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Canopy Growth Corporation (CGC) - GlobeNewsWire